Estrogen Receptor Expression in Atypical Hyperplasia: Lack of Association with Breast Cancer
暂无分享,去创建一个
R. Vierkant | D. Radisky | L. Hartmann | A. Degnim | D. Visscher | C. Reynolds | J. Boughey | S. Anderson | M. Frost | Fritcher Emily G Barr
[1] V. Vogel. The NSABP Study of Tamoxifen and Raloxifene (STAR) trial , 2009, Expert review of anticancer therapy.
[2] A. Lazaris,et al. Immunohistochemical expression of estrogen receptors alpha and beta in lobular neoplasia , 2007, Virchows Archiv.
[3] R. Vierkant,et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] S. Singletary,et al. Expression of ERα and ERβ in lobular carcinoma in situ , 2007, Histopathology.
[5] Romayne A. Thompson,et al. Age-related lobular involution and risk of breast cancer. , 2006, Journal of the National Cancer Institute.
[6] Norman Wolmark,et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. , 2006, JAMA.
[7] P. Thomas,et al. Comparison of immunohistochemistry by automated cellular imaging system (ACIS) versus fluorescence in‐situ hybridization in the evaluation of HER‐2/neu expression in primary breast carcinoma , 2006, Histopathology.
[8] S. Hilsenbeck,et al. Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer , 2005, Breast Cancer Research.
[9] L. Ford,et al. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. , 2005, Journal of the National Cancer Institute.
[10] V Shane Pankratz,et al. Benign breast disease and the risk of breast cancer. , 2005, The New England journal of medicine.
[11] K. Bloom,et al. Enhanced accuracy and reliability of HER-2/neu immunohistochemical scoring using digital microscopy. , 2004, American journal of clinical pathology.
[12] J. Sloane,et al. Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression. , 2002, The American journal of pathology.
[13] E. Frenkel,et al. Assessment of HER-2/neu status in breast cancer. Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard. , 2001, American journal of clinical pathology.
[14] S. Fuqua,et al. Histological and biological evolution of human premalignant breast disease. , 2001, Endocrine-related cancer.
[15] M. Mayo,et al. Short-term breast cancer prediction by random periareolar fine-needle aspiration cytology and the Gail risk model. , 2000, Journal of the National Cancer Institute.
[16] J. Daurès,et al. Dissociated overexpression of cathepsin D and estrogen receptor alpha in preinvasive mammary tumors. , 2000, Human pathology.
[17] J. Sloane,et al. Estrogen receptor-positive proliferating cells in the normal and precancerous breast. , 1999, The American journal of pathology.
[18] J. Sloane,et al. Oestrogen receptor expression in the normal and pre‐cancerous breast , 1999, The Journal of pathology.
[19] D. Long,et al. Immunohistologic Analysis of Estrogen Receptor Expression in Breast Carcinoma Precursor Lesions , 1998 .
[20] F. Schmitt,et al. Multistep progression from an oestrogen-dependent growth towards an autonomous growth in breast carcinogenesis. , 1995, European journal of cancer.
[21] J L Kelsey,et al. Reproductive factors and breast cancer. , 1993, Epidemiologic reviews.
[22] D. Page,et al. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. , 1992, Human pathology.
[23] G. Colditz,et al. A prospective study of benign breast disease and the risk of breast cancer , 1992, JAMA.
[24] R. Coombes,et al. Breast Estrogen and Progesterone Receptors in the Normal Female Updated Version , 2006 .
[25] A. Howell. Clinical evidence for the involvement of oestrogen in the development and progression of breast cancer , 1989 .
[26] O. Petersen,et al. Frequency and distribution of estrogen receptor-positive cells in normal, nonlactating human breast tissue. , 1987, Cancer research.
[27] W. Dupont,et al. Atypical hyperplastic lesions of the female breast: A long-term follow-up study , 1986 .
[28] W D Dupont,et al. Risk factors for breast cancer in women with proliferative breast disease. , 1985, The New England journal of medicine.
[29] T. Akiyama,et al. :A long term follow-up study , 1982 .
[30] R. Simon,et al. Estrogen receptor values in patients with benign breast disease , 1979, Cancer.